Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles tagged with "Advocacy"

Joint Letter to CMS Advocates Against Adding Stelara to Self-Administered Drug List

From the College  |  July 6, 2020

The ACR, CSRO and Arthritis Foundation asked the Centers for Medicare & Medicaid Services to review the decision to add Stelara to the Self-Administered Drugs list, which would limit access for patients who can’t self-administer.

ACR Urges Commercial Payers to Provide Relief from Prior Authorizations, Practice Disruptions

From the College  |  March 23, 2020

The ACR is urging insurance companies to expand access to telehealth services and provide relief from administrative burdens to help providers focus on patient care at this critical time.

Are Your Patients at Risk? Advocacy Matters

Kimberly Retzlaff  |  February 6, 2020

When insurance company practices put patients at risk, advocacy is an important tool physicians can use to make a real difference. You can make a difference.

New D.C. Office Strengthens ACR Advocacy Efforts

Carina Stanton  |  December 18, 2019

Three full-time, ACR advocacy staffers are now working in Washington, D.C., to provide a daily presence for national rheumatology lobbying efforts.

ACR Leverages AMA Representation to Advance Rheumatology Issues

Adam Cooper  |  November 21, 2019

The ACR’s delegation to the AMA HOD meeting in November successfully advanced resolutions to advocate for pharmacy benefit manager transparency and expanded patient protections from step therapy protocols.

Rep. Schofield and Dr. Worthing listen to an audience member's question.

1 Person Can Make a Difference: The Importance of Advocacy

Keri Losavio  |  November 11, 2019

Your voice matters: That was the shared theme of presentations by Angus Worthing, MD, FACR, FACP, William F. Harvey, MD, MSc, FACR, and Georgia Rep. Kim Schofield (D-Atlanta, Dist. 60) in the session, Raise Your Voice! Advocacy Update from Government Affairs at the 2019 ACR/ARP Annual Meeting on Monday, Nov. 11.

A Farewell Message from Outgoing Government Affairs Committee Chair Angus Worthing, MD, FACR, FACP

Angus Worthing, MD, FACP, FACR  |  November 7, 2019

A farewell message from outgoing Government Affairs Committee Chair Angus Worthing urges ACR/ARP members to advocate for the rheumatology profession.

Making Rheumatologists’ Voices Count: A Conversation with Blair Solow, MD, Incoming Government Affairs Committee Chair

Vanessa Caceres  |  November 7, 2019

With multiple healthcare policy issues currently in play, Dr. Solow believes making rheumatologists’ voices heard is crucial to the specialty’s success.

Annual Meeting Preview: Effective Advocacy By & For ACR/ARP Members

Mary Beth Nierengarten  |  October 3, 2019

Session attendees will hear about recent successes from the Government Affairs Committee and learn how to become effective rheumatology advocates.

Calling Young Rheumatologist Leaders

From the College  |  September 5, 2019

The ACR’s delegation to the AMA is seeking applicants to be a second Young Physician Section representative for the ACR.

  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 30
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences